Hydroxychloroquine-associated hyperpigmentation mimicking elder abuse

Dermatology and Therapy

Volumn 3, Issue 2, 2013, Pages 203-210

  Cohen, Philip R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abuse; Dyschromia; Elderly; Hydroxychloroquine; Hyperpigmentation; Pigmentary disorders; Pigmentation

Indexed keywords

COLLAGEN; HYDROXYCHLOROQUINE;

AGED; ARTICLE; CASE REPORT; DYSCHROMIA; ELDER ABUSE; FAMILY; FEMALE; HUMAN; HYDROXYCHLOROQUINE ASSOCIATED HYPERPIGMENTATION; HYPERPIGMENTATION; MEDICAL HISTORY; MICROSCOPY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; SKIN EXAMINATION; SWEAT GLAND; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84899856114     PISSN: None     EISSN: 21909172     Source Type: Journal    
DOI: 10.1007/s13555-013-0032-z     Document Type: Article

References (39)

1. Koranda FC. Antimalarials. J Am Acad Dermatol. 1981;4:650-5.
2. Grabstein RD, Sober AJ. Drug-and heavy metalinduced hyperpigmentation. J Am Acad Dermatol. 1981;5:1-18.
3. Wintroub BU, Stern R. Cutaneous drug reactions: pathogenesis and clinical classification. J Am Acad Dermatol. 1985;13:167-79.
4. Dereure O. Drug-induced skin pigmentation: epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2:253-62.
5. Vine JE, Hymes SR, Warner NB, Cohen PR. Pustular psoriasis induced by hydroxychloroquine: a case report and review of the literature. J Dermatol. 1996;23:357-61.
6. Skare T, Ribeiro CF, Souza FHM, Haendchen L, Jordao JM. Antimalarial cutaneous side effects: a study in 209 users. Cutan Ocular Toxicol. 2011; 30:45-9.
7. Stark S. Elder abuse: screening, intervention, and prevention. Nursing. 2012;42:24-9.
8. Yaffe MJ, Tazkarji B. Understanding elder abuse in family practice. Can Fam Physician. 2012;58: 1336-40.
9. Bond MC, Butler KH. Elder abuse and neglect: definitions, epidemiology, and approaches to emergency department screening. Clin Geriatr Med. 2013;29:257-73.
10. Palmer M, Brodell RT, Mostow EN. Elder abuse: dermatologic clues and critical solutions. J Am Acad Dermatol. 2013;68:e37-42.
11. Kalampalikis A, Goetze S, Elsner P. Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine [letter]. J Dtsch Dermatol Ges. 2012;10:921-2.
12. Melikoglu MA, Melikoglu M, Gurbuz U, Budak BS, Kacar C. Hydroxychloroquine-induced hyperpigmentation: a case report. J Clin Pharm Ther. 2008;33:699-701.
13. Rood MJ, Vermeer MH, Huizinga TWJ. Hyperpigmentation of the skin due to hydroxychloroquine [letter]. Scand J Rheumatol. 2008;37:158.
14. Cho EB, Kim BC, Park EJ, et al. Hydroxychloroquine-induced hyperpigmentation [letter]. J Dermatol. 2012;39:859-60.
15. Puri PK, Lountzis NI, Tyler W, Ferringer T. Hydroxychloroquine-induced hyperpigmentation: the staining pattern. J Cutan Pathol. 2008;35: 1134-7.
16. Tuffanelli D, Abraham RK, Dubois EI. Pigmentation from antimalarial therapy. Its possible relationship to the ocular lesions. Arch Dermatol. 1963;88: 419-26.
17. Millard TP, Kirk A, Ratnavel R. Cutaneous hyperpigmentation during therapy with hydroxychloroquine [letter]. Clin Exp Dermatol. 2004;29:92-3.
18. Morrison LK, Nordlund JJ, Heffernan MP. Persistent cutaneous hyperpigmentation due to hydroxychloroquine one year after therapy discontinuation. Dermatol Online J. 2009;15:15.
19. ChangALS, Wong JW, Endo JO, NormanRA. Geriatric dermatology. Part II. Risk factors and cutaneous signs of elder mistreatment for the dermatologist. J Am Acad Dermatol. 2013;68:533. e1-10.
20. True DG, Bryant LR, Harris MD, Bernert RA. Clinical images: hydroxychloroquine-associated mucutaneous hyperpigmentation [letter]. Arthritis Rheum. 2002;46:1698.
21. Munoz C, Chang AL. A case of Cinderella: erythema dyschromicum perstans (ashy dermatosis of dermatosis cinecienta). Skinmed. 2011;9:63-4.
22. Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologies and therapeutic considerations. Am J Clin Dermatol. 2011;12:87-9.
23. Blackshear JL, Randle HW. Reversibility of blue-gray cutaneous discoloration from amiodarone. Mayo Clin Proc. 1991;66:721-6.
24. Miller ML, Harford RR, Yeager JK, Johnson F. A case of chrysiasis. Cutis. 1997;59:256-8.
25. Cohen PR, Ross EV. Q-switched alexandrite laserinduced chrysiasis: a case report and review of the literature. J Clin Aesthet Dermatol (in press).
26. Luderschmidt C, Plewig G. Chronic mercury poisoning following topical application of skin bleachers. Klin Wochenschr. 1979;57:293-8.
27. Martinez Portillo F, Hoang-Boehm J, Weiss J, Alken P, Junemann K. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol. 2001;39:20-3.
28. Meyerson MA, Cohen PR, Hymes SR. Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:180-4.
29. Cohen PR, Tschen JA. What caused the extensive cutaneous pigmentation? (minocycline-induced cutaneous pigmentation) (Derm Dx). Skin Aging. 2003;11(7):94-6.
30. D'Agostino ML, Risser J, Robinson-Bostom L. Imipraine-induced hyperpigmentation: a case report and review of the literature. J Cutan Pathol. 2009;36:799-803.
31. Bentur Y, Shoshani O, Tabak A, et al. Prolonged elimination half-life of phenol after dermal exposure. J Toxicol Clin Toxicol. 1988;36:707-11.
32. Merchant F, Carpenter T. Blue-gray discoloration of the skin. Am Fam Physician. 2011;84:821-2.
33. Rallis E, Kintzoglou S. Ashy ears. Scientific World J. 2010;10:1530-1.
34. Sabzi F, Moloudi A. Locked-in syndrome and blue toe syndrome caused by cardiopulmonary bypass. J Tehran Heart Cent. 2010;5:150-2.
35. Caruso A, Vecchio R, Patti F, Neri S. Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis. Clin Ther. 2009;31: 580-4.
36. Chevrant-Breton J, Simon M, Bourel M, Ferrand B. Cutaneous manifestations of idiopathic hemochromatosis. Study of 100 cases. Arch Dermatol. 1977;113:161-5.
37. Sebaratnam DF, Venugopal SS, Frew JW, et al. Diffuse melanosis cutis: a systematic review of the literature. J Am Acad Dermatol. 2013;68:482-8.
38. Kkhaled A, Kerkeni N, Hawilo A, Fazaa B, Kamour MR. Endogenous ochronosis: case report and a systematic review of the literature. Int J Dermatol. 2011;50:262-7.
39. Kurzen C, Kunz I, Nigg C. Blue discoloration of hands, numbness of feet, indolent cervical lymph node swelling in a 73-year-old man. Praxis (Bern 1994). 2006;95:1589-93.